Literature
Ammann, C. A. &R. S. Safferman. 1958. The onion test as a possible screening method for antitumor agents. Antibiot. and Chemother.8: 1–7.
Asheshov, I. N., E. A. Hall &H. Flon. 1955. Action of test compounds on bacterial viruses. Amer. Ass. Cancer Res., Inc. Cancer Res. Suppl.3: 57–62.
Becker, Z. E., T. P. Suprun, E. G. Rodionova &T. V. Iangulova. 1961. Cytotoxic properties of extracts from fungal mycelium. Antibiotiki6: 108–111.
Bieber, S. &G. H. Hitchings. 1955. The developing frog embryo and growth inhibitors. Cancer Res. Suppl.3: 80–82.
Bradner, W. T. 1958. Special microbiological systems I. Anaerobic organisms. Ann. N. Y. Acad. Sci.76: 469–474.
Bradner, W. T. &D. A. Clarke. 1958. Inhibition of anaerobic bacteria as a screen for antitumor agents. Cancer Res.18: 299–304.
Bradner, W. T., A. Roth, B. Weiss &D. A. Clarke. 1957. Inhibition of anaerobic bacteria for various antitumor agents. Bact. Proc.36: 24–27.
Clarke, D. A. 1955. Mouse Sarcoma 180. Cancer Res. Suppl.3: 14–17.
DiPaolo, J. A. &P. Rosenfield. 1958. The use of anaerobes as a screening procedure for potential tumor inhibiting agents. Proc. Amer. Ass. Cancer Res.2: 292.
Endicott, K. M. 1958. Introduction. Ann. N. Y. Acad. Sci.76: 411.
Foley, G. E. 1956. Observations on the use of microbiological systems in screening potential antitumor agents. Current Res., Cancer Chemother. Rep.6: 3–22.
Foley, G. E., H. Eagle, E. E. Snell, G. W. Kidder &P. S. Thayer. 1958. Studies on the use ofin vitro procedures for the screening of potential antitumor agents: Comparison of activity in mammalian cell cultures and microbiological assays alone and in combination with experimental antitumor activity. Ann. N. Y. Acad. Sci.76: 952–960.
Foley, G. E., R. E. McCarthy, V. M. Binus, E. E. Snell, B. M. Guirard, G. W. Kidder, V. C. Dewey &P. S. Thayer. 1958. A comparative study of the use of microorganisms in the screening of potential antitumor agents. Ann. N. Y. Acad. Sci.76: 411–441.
Gause, G. F., G. V. Kochetkova &G. V. Vladimiruva. 1959. Action of anticancer substances upon the biochemical mutants of microorganisms with impared oxidation. Cancer Chermother. Rep. CCNSC. p. 48–51.
Gause, G. F. 1958. The search for anticancer antibiotics. Science127: 506–508.
Gellhorn, A. 1959. Invited remarks on the current status of research in clinical cancer chemotherapy. Cancer Chemother. Rep. CCNSC. p. 1–12.
Hirschberg, E. 1955. Some contributions of microbiology to cancer research. Bact. Rev. (reprint).19, 2.
Hirschberg, E. &G. Merson. 1955. Effect of test compounds on the aggregation and culmination of the slime moldDictyostelium discoideum. Cancer Res. Suppl.3: 76–79.
Hitchings, G. H. 1958. Special microbiological systems III. The use of lactic acid bacteria for the evaluation of purine and pyrimidine antagonists. Ann. N. Y. Acad. Sci.76: 490–496.
Hitchings, G. H. &E. B. Elion. 1955. TheLactobacillus casei screening test. Cancer Res. Suppl.3: 66–68.
Hunter, S. H., H. A. Matham, S. Aaronson, H. Baker &S. Scher. 1958. General considerations in the use of microorganisms in screening antitumor agents. Ann. N. Y. Acad. Sci.76: 457–468.
Kaplan, L. 1954. Azaserine, an inhibitor of amino acid synthesis inE. coli. Fed. Proc.13: 239.
Karnofsky, D. A. 1955. Assay of chemotherapeutic agents of the developing chick embryo. Cancer Res. Suppl.3: 83–85.
Kohberger, D. L., H. C. Reilly, G. L. Coffey, A. B. Hillegas &J. Ehrlich. 1955. Azaserine yeast assay withKloeckera brevis. Antibiot. and Chemother.5, 2.
Maxwell, R. E. 1954. Filament formation inE. coli induced azaserine and other antineoplastic agents. Science120: 270–271.
McKenna, G. F., A. Taylor &N. Carmichael. 1958. Cancer chemotherapy with plant extracts. Texas Reports on Biol. Med.16: 203–214.
Mickelson, M. N. &R. S. Flippin. 1958. Effects of certain amino acid derivatives on microorganisms and Sarcoma 180. Excerpta Med. Cancer6.
Reilly, H. C. 1955. An evaluation of the use of anticrobial activity as a screening procedure for tumor inhibiting agents. Cancer Res. Suppl.3: 63–66.
Reilly, H. C. 1953. Microbiology and cancer therapy: A review. Cancer Res.13: 821–834.
Reilly, H. C., C. C. Stock, S. M. Buckley, D. A. Clarke &C. P. Rhoads. 1954. The screening of crude metabolic filtrates of soil microorganisms for ability to inhibit the growth of Sarcoma 180in vivo. Antibiotics Ann.: 1002–1008.
Schnabel, F. M. 1958. Utility of drug resistant organisms in cancer chemotherapy studies. Ann. N. Y. Acad. Sci.76: 442–456.
Schultz, J., N. Rothman &M. M. Aronson. 1955. The growth and morphogenesis ofDrosophila melanogaster as criteria for screening tests. Cancer Res. Suppl.3: 86–97.
Szybalski, W. 1958. Special microbiological systems II. Observations on chemical mutagenesis in microorganisms. Ann. N. Y. Acad. Sci.76: 467–489.
Woody, P. L., J. D. Mendell &J. Greenberg. 1961. Resistance and cross resistance ofEscherichia coli mutants to anticancer agents. Radiat. Res.15: 290–297.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volz, P.A., Beneke, E.S. An aquatic fungal bio-assay method for detection of carcinostatic agents. Mycopathologia et Mycologia Applicata 30, 97–114 (1966). https://doi.org/10.1007/BF02130356
Issue Date:
DOI: https://doi.org/10.1007/BF02130356